Fifty410 Pricing: Semaglutide Monthly vs Tirzepatide Prepaid Costs

Last reviewed: September 15, 2026 Last updated: September 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Fifty410 does not use a first-month promotional price. Semaglutide runs $199 per month with monthly billing; tirzepatide comes in three dose tiers—starter ($399), mid ($499), and high ($549)—billed as a single upfront payment that covers a 3-month supply. Over a full year, the tirzepatide structure yields effective monthly rates of $133 to $183 (our calculation), while semaglutide remains $199 every month. The "long-term cost" question hinges on whether you're willing to prepay a quarter at a time and which compound and dose you need.

At-a-glance: Fifty410 pricing structure

Source: fifty410.com/pricing/semaglutide and /tirzepatide, captured September 4, 2026. Twelve-month totals and per-month equivalents are our calculation. All prices include consult, medication, and shipping; no membership fee.

Fifty410's pricing model: no first-month discount, no membership

Fifty410 advertises the same rate for every billing cycle—there is no introductory or promotional price that changes after the first month. Semaglutide costs $199 every time you're billed, once a month. Tirzepatide charges the same upfront amount ($399, $499, or $549 depending on dose) every time you order a 3-month supply. You pay only if a provider writes a prescription, and the advertised price bundles the consult, medication, and shipping with no separate membership or platform fee.

The pricing page, captured September 4, 2026, is the current authoritative source; Fifty410's help center historically listed different tiers, but we rely on the public pricing pages verified most recently. These prices have not been confirmed through a completed checkout in our evidence set—always confirm the final amount before submitting payment.

Semaglutide: $199 monthly, $2,388 per year

Fifty410 bills semaglutide at $199 once a month, covering a 4-week supply. Multiply by 12 and the annual outlay is $2,388. Because billing happens monthly, your cash flow matches the calendar—you're never prepaying more than 30 days ahead. If you stop treatment or switch providers mid-year, you've only paid for the months you used.

By comparison, PlexusDx charges $189/month month-to-month for compounded semaglutide injection—$10 less each cycle, or $120 less over a full year. PlexusDx also offers 3-month ($169/month) and 6-month ($149/month) prepaid plans that lower the effective rate further, though those figures require committing multiple months upfront.

Tirzepatide: dose-tiered prepaid packages

Fifty410 structures tirzepatide as three separate 3-month packages, each corresponding to a dose range:

• Starter dose: $399 upfront for 3 months—$133 per month over that period (our calculation).
• Mid dose: $499 upfront—$166 per month equivalent.
• High dose: $549 upfront—$183 per month equivalent.

All three tiers ship the full 3-month supply at once. You pay the total amount before the first dose arrives, and Fifty410 does not set up an automatic recurring subscription—you reorder manually when the quarter ends.

Over 12 months, you would place four orders. A patient on the starter tier all year pays $399 × 4 = $1,596 total; mid tier totals $1,996; high tier totals $2,196. Those annual figures translate to effective monthly rates of $133, $166, and $183 respectively—our calculation, not advertised as such by Fifty410.

Head-to-head: Fifty410 vs PlexusDx over 12 months

PlexusDx figures are month-to-month rates; PlexusDx also offers 3-month and 6-month plans at lower effective rates, which would narrow these gaps, but exact tirzepatide multi-month pricing was not quantified in our evidence set. All calculations ours.

Fifty410's tirzepatide is materially less expensive—between $1,272 and $1,872 lower over a year, depending on dose—while its semaglutide costs $120 more than PlexusDx's month-to-month rate. The tirzepatide advantage shrinks if you compare Fifty410's prepaid model against PlexusDx's own 3-month or 6-month tirzepatide plans, but we lack the exact figures to quantify that narrower comparison.

What the prepaid model means for cash flow and commitment

Fifty410's tirzepatide structure delivers a lower effective monthly rate by asking you to fund three months at once. That trade-off has practical implications:

• Upfront cash requirement: You need $399 to $549 in hand before the first shipment, rather than spreading the cost across three separate $133–$183 charges. If budget timing matters—especially early in treatment when out-of-pocket costs are less predictable—a monthly plan may fit better even if the annual total is higher.
• Dose-escalation cost jumps: Many patients titrate from starter to mid or high dose over the first months. Under Fifty410's model, moving up a tier means paying the higher package price for the next 3-month block. If you escalate halfway through a cycle, you've already prepaid the lower dose and will pay the higher rate sooner than you would under a monthly plan that adjusts each billing period.
• No recurring subscription: Fifty410 ships the full quarter upfront and does not auto-renew. You reorder manually when the supply runs low. That avoids surprise charges but requires you to remember to reorder; a lapse could interrupt treatment.
• Limited mid-cycle flexibility: If side effects, insurance changes, or personal circumstances lead you to stop treatment two months into a prepaid quarter, you've already paid for the third month. Monthly billing limits your sunk cost to 30 days.

PlexusDx's month-to-month tirzepatide plan charges $289 once a month with no prepayment, so your financial commitment never extends beyond the current cycle. That structure costs $3,468 over 12 months if you stay on treatment the entire year—substantially more than Fifty410's $1,596 to $2,196 range—but it preserves cash-flow predictability and mid-cycle exit flexibility.

Service quality and reported experience

Fifty410 holds a 4.8-star rating across 5,891 reviews on Trustpilot (provider page claim, captured September 4, 2026). That aggregate score places it among the higher-rated compounded GLP-1 programs we track. By comparison, PlexusDx holds a 4.3-star rating on Trustpilot, with 79 percent of reviews at five stars and 83 percent at four stars or higher (captured September 9, 2026).

We searched Reddit and indexed Trustpilot results for negative themes but did not capture specific attributable complaints in our September 4 evidence pull. The high review volume and strong average suggest that most patients report satisfactory experiences, though individual reports of shipping delays, dosing questions, or customer-service responsiveness appear in any program's review history. Confirm current service patterns by reading recent dated reviews on Trustpilot before committing a 3-month prepayment.

Choose Fifty410 if…

• You need tirzepatide and want the lowest annual cost available in our comparison set—Fifty410's $1,596 to $2,196 per year is $1,272 to $1,872 less than PlexusDx's month-to-month rate.
• You can prepay $399–$549 every quarter without straining your budget, and you prefer fewer transactions over the year.
• You value no recurring subscription—you reorder manually rather than managing auto-renewals.
• You are confident you will stay on the same dose tier for at least three months so the prepaid package matches your clinical trajectory.

Choose PlexusDx if…

• You want monthly cash flow with no upfront multi-month commitment—PlexusDx charges once a month, so your financial exposure never exceeds 30 days.
• You need semaglutide and prefer the lowest available monthly rate—PlexusDx runs $189/month vs Fifty410's $199, saving $120 over a year.
• You expect to titrate doses frequently in the first months and want billing that adjusts each cycle rather than locking in a 3-month tier.
• You value mid-cycle flexibility—if you need to pause or switch, you've only paid for the current month rather than a prepaid quarter.

Methodology and freshness

We captured Fifty410's public pricing pages (fifty410.com/pricing/semaglutide and /tirzepatide) on September 4, 2026, at 13:49:55 UTC. Those pages listed the $199 monthly semaglutide rate and the three tirzepatide tiers ($399 / $499 / $549 for 3-month supplies). We did not complete a checkout flow, so final cart totals may differ; confirm all figures at fifty410.com before payment.

PlexusDx's month-to-month rates ($189 semaglutide, $289 tirzepatide) were documented between July 17 and July 23, 2026, and remain current as of September 15, 2026. PlexusDx also offers 3-month and 6-month plans at lower effective rates; exact tirzepatide figures for those commitments were not quantified in our evidence set, so we used month-to-month pricing for the comparison tables.

Trustpilot ratings for Fifty410 (4.8 stars, 5,891 reviews) were captured from the provider page on September 4, 2026. PlexusDx's Trustpilot record (4.3 stars, 79 percent five-star, 83 percent four-star or higher) was captured September 9, 2026, from trustpilot.com/review/plexusdx.com.

All 12-month totals and per-month equivalents are our calculation: we multiplied the advertised cycle price by the number of cycles per year and divided annual totals by 12 to produce effective monthly rates. Pricing structures, inclusions, and billing models may change; verify all details on the provider's current website.

Frequently Asked Questions

Does Fifty410 charge less for the first month?

No. Fifty410 does not use a promotional or introductory first-month rate. Semaglutide costs $199 every month, and tirzepatide costs the same upfront amount ($399, $499, or $549 depending on dose) every time you order a 3-month supply. The advertised prices are standard ongoing rates.

What's included in Fifty410's tirzepatide price?

Each tirzepatide package ($399 starter, $499 mid, $549 high) covers the provider consult, a 3-month supply of compounded medication, and shipping to your door. Fifty410 charges no separate membership or platform fee. You pay the single upfront amount and receive the full quarter's supply in one shipment.

How does the dose-tier system work if I need to increase my dose?

If your provider raises your dose mid-cycle, you will pay the higher tier price when you reorder the next 3-month supply. For example, if you start on the $399 starter package and escalate to mid dose after two months, your next order will cost $499 for the following three months. You cannot prorate or adjust the current prepaid cycle.

Is Fifty410's compounded tirzepatide the same as branded Mounjaro or Zepbound?

No. Compounded medications are not FDA-approved and are not reviewed by FDA before marketing for safety, effectiveness, or quality. Fifty410's tirzepatide is produced by a compounding pharmacy and differs from the branded drugs Mounjaro and Zepbound, which are FDA-approved products manufactured by Eli Lilly. A licensed clinician determines whether a compounded prescription is appropriate for your individual situation.

Can I cancel Fifty410 mid-quarter if I've already prepaid?

Fifty410 does not run a recurring subscription, so there is no automatic renewal to cancel. However, once you pay for a 3-month supply upfront, that payment covers the full quarter's medication. If you stop treatment partway through, you have already funded the remaining weeks. Check Fifty410's refund and cancellation policy on its website for specific terms.

Sources

• Fifty410 Semaglutide Pricing, fifty410.com/pricing/semaglutide, accessed September 4, 2026
• Fifty410 Tirzepatide Pricing, fifty410.com/pricing/tirzepatide, accessed September 4, 2026
• Fifty410 Trustpilot Profile, trustpilot.com/review/fifty410.com, accessed September 4, 2026
• PlexusDx Trustpilot Profile, trustpilot.com/review/plexusdx.com, accessed September 9, 2026
• PlexusDx Internal Pricing Documentation, July 17–23, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.